Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease

Epidemiological investigation of the prevalence of von Willebrand's disease

1987 • 956 citations

von Willebrand factor and von Willebrand disease [published erratum appears in Blood 1988 Mar;71(3):830]

1987 • 435 citations

Stabilization of Factor VIII in Plasma by the von Willebrand Factor

1977 • 421 citations

Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs

1975 • 400 citations

Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes

1982 • 369 citations

Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's Disease

1981 • 314 citations

von Willebrand factor and von Willebrand disease [published erratum appears in Blood 1988 Mar;71(3):830]

1987 • 311 citations

Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders [see comments]

1988 • 301 citations

Drugs Five Years Later: Desmopressin

1985 • 263 citations

Platelet Aggregation Induced by I-Desamino-8-D-Arginine Vasopressin (dDAVP) in Type IIb von Willebrand's Disease

1983 • 260 citations

Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders [see comments]

1988 • 237 citations

New variant of von Willebrand disease with defective binding to factor VIII

1989 • 234 citations

Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).

1986 • 217 citations

Acquired von Willebrand's disease in the myeloproliferative syndrome

1984 • 213 citations

Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects

1986 • 206 citations

Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor

1985 • 187 citations

Response of Patients with Mild and Moderate Hemophilia A and von Willebrand's Disease to Treatment with Desmopressin

1985 • 166 citations

Hyponatremia and seizures in young children given ddavp

1989 • 160 citations

Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies

1984 • 158 citations

Serial studies in von Willebrand's disease: variability versus "variants"

1980 • 155 citations

Studies on the prolonged bleeding time in von Willebrand's disease.

1976 • 148 citations

Intranasal and Intravenous Administration of Desmopressin: Effect on F VIII/vWF, Pharmacokinetics and Reproducibility

1987 • 143 citations

Epsilon‐Aminocaproic Acid Therapy for Dental Extractions in Haemophilia and Christmas Disease: A Double Blind Controlled Trial

1971 • 140 citations

Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC).

1982 • 136 citations

von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers

1988 • 125 citations

Myocardial infarction in a patient with hemophilia treated with DDAVP.

1988 • 121 citations

Thrombosis following desmopressin for uremic bleeding

1988 • 114 citations

Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.

1983 • 104 citations

Brief Report: Correction of the Hemostatic Defects in Von Willebrand’s Disease

1967 • 100 citations

DDAVP: A useful alternative to blood components in moderate hemophilia A and von Willebrand disease

1983 • 100 citations

Factor VIII and Fibrinolytic Response to Deamino‐8‐<scp>d</scp>‐Argenine Vasopressin in Normal Subjects and Dissociate Response in Some Patients with Haemophilia and von Willebrand's Disease

1980 • 98 citations

Desmopressin (DDAVP) for treatment of disorders of hemostasis.

1986 • 95 citations

Atherosclerosis and von Willebrand factor

1984 • 93 citations

Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activities.

1976 • 90 citations

A new von Willebrand variant (type I, New York): increased ristocetin- induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers

1986 • 89 citations

Von Willebrand factor multimer patterns in von Willebrand's disease

1983 • 87 citations

Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses.

1987 • 79 citations

Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia A

1989 • 74 citations

High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC)

1985 • 64 citations

The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors

1986 • 59 citations

von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma

1986 • 57 citations

Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients

2008 • 55 citations

Association between Factor VIII Related Antigen and Plasminogen Activator

1982 • 55 citations

Severe hyponatremia after repeated intravenous administration of desmopressin

1989 • 53 citations

DESMOPRESSIN AND MYOCARDIAL INFARCTION

1989 • 52 citations

A variant of von Willebrand's disease characterized by recessive inheritance and missing triplet structure of von Willebrand factor multimers

1983 • 47 citations

DDAVP in type IIa von Willebrand's disease

1986 • 47 citations

DDAVP in acquired von Willebrand syndrome associated with multiple myeloma

1986 • 46 citations

Hyper‐responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra‐platelet von Willebrand factor

1988 • 45 citations

DDAVP for type IIB von Willebrand disease [letter]

1989 • 42 citations

A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF)

1986 • 42 citations

Hemostatic effect of a heat-treated factor VIII concentrate (Haemate P) in von Willebrand's disease

1988 • 38 citations

DDAVP in Von Willebrand's disease: Repeated administration and the behaviour of the bleeding time

1978 • 34 citations

A variant of type II von willebrand disease with an abnormal triplet structure and discordant effects of protease inhibitors on plasma and platelet von willebrand factor structure

1987 • 32 citations

Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia.

1980 • 22 citations

Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy

1989 • 21 citations

Humate-P for treatment of von Willebrand disease [letter]

1988 • 20 citations

Type II H von willebrand disease: New structural abnormality of plasma and platelet von willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity

1989 • 17 citations

Clinical evaluation of subcutaneously administered DDAVP

1988 • 16 citations

Unique multimeric pattern of von Willebrand factor in a patient with a benign monoclonal gammopathy

1986 • 8 citations

Response to desmopressin in type IID von Willebrand's disease

1989 • 5 citations